News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
151,584 Results
Type
Article (8173)
Company Profile (41)
Press Release (143362)
Multimedia
Podcasts (12)
Webinars (5)
Section
Business (43571)
Career Advice (244)
Deals (5221)
Drug Delivery (20)
Drug Development (21325)
Employer Resources (35)
FDA (2634)
Job Trends (3634)
News (72243)
Policy (5263)
Tag
Academia (924)
Accelerated approval (5)
Adcomms (4)
Allergies (43)
Alliances (12105)
ALS (64)
Alzheimer's disease (654)
Antibody-drug conjugate (ADC) (89)
Approvals (2721)
Artificial intelligence (176)
Autoimmune disease (42)
Automation (13)
Bankruptcy (31)
Best Places to Work (3198)
BIOSECURE Act (1)
Biosimilars (44)
Biotechnology (23)
Bladder cancer (41)
Brain cancer (16)
Breast cancer (205)
Cancer (1425)
Cardiovascular disease (177)
Career advice (229)
Career pathing (11)
CAR-T (76)
CDC (10)
Cell therapy (207)
Cervical cancer (6)
Clinical research (17699)
Collaboration (571)
Compensation (69)
Complete response letters (7)
COVID-19 (744)
CRISPR (45)
C-suite (308)
Cystic fibrosis (51)
Data (2242)
Denatured (5)
Depression (42)
Diabetes (152)
Diagnostics (1647)
Digital health (6)
Diversity (3)
Diversity, equity & inclusion (10)
Drug discovery (100)
Drug pricing (17)
Drug shortages (3)
Duchenne muscular dystrophy (75)
Earnings (11852)
Editorial (13)
Employer branding (7)
Employer resources (34)
Events (23839)
Executive appointments (338)
FDA (3393)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (1)
Frontotemporal dementia (10)
Funding (493)
Gene editing (78)
Generative AI (16)
Gene therapy (188)
GLP-1 (254)
Government (964)
Grass and pollen (1)
Guidances (86)
Healthcare (3887)
HIV (27)
Huntington's disease (10)
IgA nephropathy (23)
Immunology and inflammation (51)
Immuno-oncology (14)
Indications (28)
Infectious disease (816)
Inflammatory bowel disease (66)
Inflation Reduction Act (1)
Influenza (29)
Intellectual property (54)
Interviews (34)
IPO (2045)
IRA (7)
Job creations (624)
Job search strategy (202)
JPM (15)
Kidney cancer (2)
Labor market (15)
Layoffs (96)
Leadership (7)
Legal (888)
Liver cancer (21)
Longevity (6)
Lung cancer (184)
Lymphoma (91)
Machine learning (21)
Management (11)
Manufacturing (189)
MASH (55)
Medical device (1857)
Medtech (1867)
Mergers & acquisitions (3410)
Metabolic disorders (379)
Multiple sclerosis (50)
NASH (5)
Neurodegenerative disease (115)
Neuropsychiatric disorders (26)
Neuroscience (1065)
Neurotech (1)
NextGen: Class of 2026 (1276)
Non-profit (1416)
Now hiring (11)
Obesity (168)
Opinion (72)
Ovarian cancer (39)
Pain (52)
Pancreatic cancer (57)
Parkinson's disease (105)
Partnered (10)
Patents (90)
Patient recruitment (123)
Peanut (14)
People (18780)
Pharmaceutical (8)
Pharmacy benefit managers (1)
Phase 1 (5271)
Phase 2 (7468)
Phase 3 (6226)
Pipeline (1490)
Policy (61)
Postmarket research (664)
Preclinical (3456)
Press Release (33)
Prostate cancer (70)
Psychedelics (17)
Radiopharmaceuticals (55)
Rare diseases (251)
Real estate (1248)
Recruiting (15)
Regulatory (4466)
Reports (8)
Research institute (1051)
Resumes & cover letters (24)
Rett syndrome (8)
RNA editing (5)
RSV (13)
Schizophrenia (36)
Series A (106)
Series B (38)
Sickle cell disease (40)
Special edition (1)
Spinal muscular atrophy (69)
Sponsored (19)
Startups (1197)
State (1)
Stomach cancer (3)
Supply chain (16)
Tariffs (6)
The Weekly (7)
Vaccines (236)
Venture capital (22)
Weight loss (77)
Women's health (28)
Worklife (2)
Date
Today (4)
Last 7 days (158)
Last 30 days (631)
Last 365 days (8208)
2026 (783)
2025 (8149)
2024 (8868)
2023 (10133)
2022 (12901)
2021 (14122)
2020 (12487)
2019 (10036)
2018 (7698)
2017 (7857)
2016 (7576)
2015 (8162)
2014 (5961)
2013 (4756)
2012 (4881)
2011 (5147)
2010 (4329)
Location
Africa (170)
Alabama (20)
Alaska (4)
Arizona (46)
Arkansas (2)
Asia (8387)
Australia (1403)
California (2696)
Canada (869)
China (279)
Colorado (128)
Connecticut (123)
Delaware (88)
Europe (23197)
Florida (345)
Georgia (86)
Hawaii (1)
Idaho (10)
Illinois (170)
India (11)
Indiana (97)
Iowa (5)
Japan (121)
Kansas (20)
Kentucky (6)
Louisiana (10)
Maine (50)
Maryland (328)
Massachusetts (2422)
Michigan (109)
Minnesota (95)
Mississippi (2)
Missouri (38)
Montana (5)
Nebraska (8)
Nevada (24)
New Hampshire (15)
New Jersey (751)
New Mexico (21)
New York (894)
North Carolina (356)
North Dakota (3)
Northern California (1321)
Ohio (100)
Oklahoma (9)
Oregon (22)
Pennsylvania (563)
Puerto Rico (4)
Rhode Island (17)
South America (197)
South Carolina (6)
Southern California (1063)
Tennessee (39)
Texas (464)
United States (10307)
Utah (115)
Vermont (1)
Virginia (63)
Washington D.C. (15)
Washington State (242)
West Virginia (1)
Wisconsin (40)
151,584 Results for "elixirgen scientific".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioCapital
Elixirgen Scientific Achieves ISO 9001 QMS Certification
Baltimore-based biotechnology leader, Elixirgen Scientific, Inc., achieves ISO 9001:2015 Quality Management System certification, strengthening commitment to quality, excellence in biotechnology and drug discovery.
March 12, 2024
·
3 min read
Elixirgen Scientific, Inc. Achieves ISO 9001:2015 Certification, Strengthening Commitment to Quality, Excellence in Biotechnology
Elixirgen Scientific, Inc., a biotechnology leader focused on advancing drug discovery and revolutionizing cell therapy through iPSC technology, announced today that it has been accredited for ISO 9001:2015 certification.
March 8, 2024
·
3 min read
BioCapital
Elixirgen Therapeutics Presents Preclinical Data with Bobcat mRNATM Technology in Duchenne Muscular Dystrophy at the 2024 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
Elixirgen Therapeutics, Inc., today presented preclinical data on its proprietary Bobcat mRNA TM technology in a poster presentation at the 2024 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference taking place March 3-6, 2024, in Orlando, Florida.
March 4, 2024
·
2 min read
Press Releases
Elixirgen Therapeutics Granted FDA Orphan Drug Designation for EXG-34217 for Treatment of Telomere Biology Disorders
February 21, 2025
·
2 min read
News
Elixirgen Scientific Launches Advanced hiPSC-Derived Disease Panel for Alzheimer’s Disease
July 16, 2024
·
2 min read
Press Releases
Elixirgen Therapeutics Publishes Early Results Showing Telomere Elongation in First Gene Therapy Trial for Telomere Biology Disorders
February 25, 2025
·
5 min read
Press Releases
Elixirgen Therapeutics Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for EXG-34217 for Treatment of Telomere Biology Disorders
February 14, 2025
·
2 min read
Press Releases
Eurobio Scientific: 2025 FY revenue
January 28, 2026
·
4 min read
Press Releases
TempraMed Appoints Leading Diabetes Researcher Professor Dr. Lutz Heinemann to its Scientific Advisory Board
A renowned expert in insulin pharmacology, diabetes technology, and temperature-sensitive medication stability joins TempraMed to strengthen scientific leadership
December 10, 2025
·
6 min read
Press Releases
Elixirgen Therapeutics Receives Rare Pediatric Disease Designation for EXG-34217 in Dyskeratosis Congenita and Related Telomere Biology Disorders
September 26, 2024
·
2 min read
1 of 15,159
Next
